ClinVar Genomic variation as it relates to human health
NM_000173.7(GP1BA):c.763A>G (p.Met255Val)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_000173.7(GP1BA):c.763A>G (p.Met255Val)
Variation ID: 4155 Accession: VCV000004155.11
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 17p13.2 17: 4933367 (GRCh38) [ NCBI UCSC ] 17: 4836662 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Apr 4, 2013 Apr 23, 2022 Jul 16, 2021 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_000173.7:c.763A>G MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_000164.5:p.Met255Val missense NC_000017.11:g.4933367A>G NC_000017.10:g.4836662A>G NG_008767.2:g.6073A>G LRG_480:g.6073A>G LRG_480t1:c.763A>G LRG_480p1:p.Met255Val P07359:p.Met255Val - Protein change
- M255V
- Other names
-
M239V
- Canonical SPDI
- NC_000017.11:4933366:A:G
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
- -
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
GP1BA | - | - |
GRCh38 GRCh37 |
182 | 240 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Pathogenic (2) |
criteria provided, single submitter
|
- | RCV000004372.13 | |
Likely pathogenic (1) |
criteria provided, single submitter
|
Feb 1, 2019 | RCV000851872.9 | |
Likely pathogenic (1) |
criteria provided, single submitter
|
Feb 1, 2019 | RCV000851873.9 | |
Pathogenic (1) |
criteria provided, single submitter
|
Jul 16, 2021 | RCV001810831.13 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Likely pathogenic
(Feb 01, 2019)
|
criteria provided, single submitter
Method: research
|
Thrombocytopenia
Affected status: yes
Allele origin:
unknown
|
NIHR Bioresource Rare Diseases, University of Cambridge
Study: ThromboGenomics
Accession: SCV000899905.1 First in ClinVar: Sep 29, 2019 Last updated: Sep 29, 2019 |
Sex: male
Ethnicity/Population group: South-Asian
|
|
Likely pathogenic
(Feb 01, 2019)
|
criteria provided, single submitter
Method: research
|
Impaired ristocetin-induced platelet aggregation
Affected status: yes
Allele origin:
unknown
|
NIHR Bioresource Rare Diseases, University of Cambridge
Study: ThromboGenomics
Accession: SCV000899906.1 First in ClinVar: Sep 29, 2019 Last updated: Sep 29, 2019 |
Sex: female
Ethnicity/Population group: European
|
|
Pathogenic
(-)
|
criteria provided, single submitter
Method: clinical testing
|
Pseudo von Willebrand disease
Affected status: yes
Allele origin:
de novo,
unknown,
paternal
|
ISTH-SSC Genomics in Thrombosis and Hemostasis, KU Leuven, Center for Molecular and Vascular Biology
Accession: SCV002500881.1
First in ClinVar: Apr 23, 2022 Last updated: Apr 23, 2022
Comment:
GoldVariant submitters: Loredana Bury, University of Perugia, Department of Medicine and Surgery, Centre for Hemostasis and Thrombosis, Italy; Maha Othman for Seattle Institute for Biomedical … (more)
GoldVariant submitters: Loredana Bury, University of Perugia, Department of Medicine and Surgery, Centre for Hemostasis and Thrombosis, Italy; Maha Othman for Seattle Institute for Biomedical and Clinical Research, Seattle, USA; Hemophilia Treatment Center, North Shore Long Island Jewish Health System, Cohen Children’s, Long Island, USA and Niigata University School of Medicine, Niigata, Japan (less)
|
Observation 1:
Family history: no
Ethnicity/Population group: Caucasian
Observation 2: Observation 3: Observation 4: Observation 5: Observation 6: Observation 7: Observation 8: Observation 9: Observation 10: Observation 11: Observation 12: |
|
Pathogenic
(Jul 16, 2021)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: unknown
Allele origin:
germline
|
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Accession: SCV002048708.1
First in ClinVar: Jan 08, 2022 Last updated: Jan 08, 2022 |
Comment:
The GP1BA c.763A>G; p.Met255Val variant (rs121908064), also known as Met239Val in alternate nomenclature, is reported in the literature in multiple individuals affected with pseudo-von Willebrand … (more)
The GP1BA c.763A>G; p.Met255Val variant (rs121908064), also known as Met239Val in alternate nomenclature, is reported in the literature in multiple individuals affected with pseudo-von Willebrand disease, also called platelet-type von Willebrand disease (Desai 2015, Giannini 2010, Kunishima 1997, Russell 1993, Takahashi 1995). This variant was observed to co-segregate with disease in several small kindreds (Russell 1993, Takahashi 1995) and was confirmed to have arisen de novo in another family (Kunishima 1997). The p.Met255Val variant is absent from general population databases (Exome Variant Server, Genome Aggregation Database), indicating it is not a common polymorphism. The methionine at codon 255 is weakly conserved, and computational analyses are uncertain whether this variant is neutral or deleterious (REVEL: 0.308). However, functional analyses of patient megakaryocytes with this variant exhibit increased binding to von Willebrand factor (Bury 2019). Based on available information, this variant is considered to be pathogenic. References: Bury L et al. Mechanisms of thrombocytopenia in platelet-type von Willebrand disease. Haematologica. 2019 Jul;104(7):1473-1481. PMID: 30655369. Desai DS et al. Elderly female with a personal and family history of a bleeding disorder. Clin Chem. 2015 Jul;61(7):909-12. PMID: 26116638. Giannini S et al. Diagnosis of platelet-type von Willebrand disease by flow cytometry. Haematologica. 2010 Jun;95(6):1021-4. PMID: 19951970. Kunishima S et al. De novo mutation of the platelet glycoprotein Ib alpha gene in a patient with pseudo-von Willebrand disease. Blood Coagul Fibrinolysis. 1997 Jul;8(5):311-5. PMID: 9282797. Russell SD and Roth GJ. Pseudo-von Willebrand disease: a mutation in the platelet glycoprotein Ib alpha gene associated with a hyperactive surface receptor. Blood. 1993 Apr 1;81(7):1787-91. PMID: 8384898. Takahashi H et al. Substitution of Val for Met at residue 239 of platelet glycoprotein Ib alpha in Japanese patients with platelet-type von Willebrand disease. Blood. 1995 Feb 1;85(3):727-33. PMID: 7833477. (less)
|
|
Pathogenic
(Apr 01, 1993)
|
no assertion criteria provided
Method: literature only
|
VON WILLEBRAND DISEASE, PLATELET-TYPE
Affected status: not provided
Allele origin:
germline
|
OMIM
Accession: SCV000024543.1
First in ClinVar: Apr 04, 2013 Last updated: Apr 04, 2013 |
Comment on evidence:
In a father and 2 daughters with pseudo-von Willebrand disease (177820), Russell and Roth (1993) demonstrated an A-to-G transition in codon 239 that resulted in … (more)
In a father and 2 daughters with pseudo-von Willebrand disease (177820), Russell and Roth (1993) demonstrated an A-to-G transition in codon 239 that resulted in substitution of valine for methionine (M239V). The abnormal receptor displayed increased affinity for its ligand, von Willebrand factor. (less)
|
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
GoldVariants, a resource for sharing rare genetic variants detected in bleeding, thrombotic, and platelet disorders: Communication from the ISTH SSC Subcommittee on Genomics in Thrombosis and Hemostasis. | Megy K | Journal of thrombosis and haemostasis : JTH | 2021 | PMID: 34355501 |
Diagnostic high-throughput sequencing of 2396 patients with bleeding, thrombotic, and platelet disorders. | Downes K | Blood | 2019 | PMID: 31064749 |
Pseudo-von Willebrand disease: a mutation in the platelet glycoprotein Ib alpha gene associated with a hyperactive surface receptor. | Russell SD | Blood | 1993 | PMID: 8384898 |
Text-mined citations for rs121908064 ...
HelpRecord last updated Nov 03, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.